Spruce Biosciences, Inc. (SPRB) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$16.51M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$11.99M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$8.23M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.69M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2022-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$16.51M | (m) | (m) | (m) | $135.00K* | -$22.12M* | (m) | $12.16M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$11.99M | (m) | (m) | (m) | $10.00K | -$8.73M | (m) | $7.58M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$8.23M | (m) | (m) | (m) | (m) | -$5.32M* | (m) | $5.01M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$2.69M | (m) | (m) | (m) | $0.00* | -$8.83M* | (m) | -$430.00K | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$14.49M | (m) | (m) | (m) | $0.00 | -$12.73M | (m) | $10.84M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$9.41M | (m) | (m) | (m) | (m) | -$9.22M* | (m) | $6.55M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$10.04M | (m) | (m) | (m) | (m) | -$11.11M* | (m) | $8.09M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$12.63M | (m) | (m) | (m) | (m) | -$14.96M | (m) | $10.32M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$13.66M | (m) | (m) | (m) | $7.00K* | -$12.27M* | (m) | $13.49M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$13.97M | (m) | (m) | (m) | (m) | $1.99M* | (m) | $13.13M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$13.20M | (m) | (m) | (m) | (m) | -$11.79M | (m) | $11.71M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$11.56M | (m) | (m) | (m) | $2.00K* | -$8.58M* | (m) | $8.79M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$11.88M* | -$11.88M | $6.00K* | (m) | (m) | (m) | -$9.54M* | (m) | $9.06M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$11.71M | (m) | (m) | (m) | (m) | (m) | -$11.83M | (m) | $8.51M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$9.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$11.38M* | -$11.40M | $18.00K* | (m) | (m) | $65.00K* | -$7.60M* | (m) | $8.61M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$11.70M* | -$11.71M | $17.00K* | (m) | (m) | $3.00K* | -$9.69M* | (m) | $9.12M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$9.8M | (m) | (m) | (m) | (m) | $19.00K | -$8.79M | (m) | $6.71M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$8.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$9.55M* | -$9.56M | $8.00K* | (m) | (m) | $43.00K* | -$7.60M* | (m) | $7.77M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$6.37M* | -$6.39M | $17.00K* | (m) | (m) | (m) | -$4.70M* | (m) | $5.66M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$5.13M | (m) | (m) | (m) | (m) | (m) | -$5.96M | (m) | $4.61M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$3.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$2.56M | (m) | (m) | (m) | (m) | (m) | (m) | $2.11M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$36.51M | (m) | (m) | (m) | (m) | -$33.33M | (m) | $19.52M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$56.15M | (m) | (m) | (m) | $0.00 | -$55.96M | (m) | $46.42M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$51.99M | (m) | (m) | (m) | $7.00K | -$33.27M | (m) | $49.43M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$47.28M | (m) | (m) | (m) | $8.00K | -$41.68M | (m) | $35.20M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$42M | (m) | (m) | (m) | (m) | $93.00K | -$35.88M | (m) | $30.70M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$29.38M | (m) | (m) | (m) | (m) | $74.00K | -$27.52M | (m) | $23.85M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$13.1M | (m) | (m) | (m) | (m) | $4.00K | -$12.62M | (m) | $10.82M | (m) | $0.00 |
|---|